Ecklonia cava ethanolic extracts inhibit lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in BV2 microglia via the MAP kinase and NF-κB pathways

Food and Chemical Toxicology

Volumn 47, Issue 2, 2009, Pages 410-417

  Jung, Won Kyo ^a   Ahn, Young Wook ^b   Lee, Sang Hoon ^b   Choi, Yung Hyun ^c   Kim, Se Kwon ^b   Yea, Sung Su ^d   Choi, Inhak ^e   Park, Sae Gwang ^e   Seo, Su Kil ^e   Lee, Soo Woong ^e   Choi, Il Whan ^e  

^a Chosun University   (South Korea)

^b Pukyong National University   (South Korea)

^c Dong Eui University   (South Korea)

^d Inje University College of Medicine   (South Korea)

^e Center for Viral Disease Research   (South Korea)

Author keywords

Cyclooxygenase 2; Ecklonia cava; Inducible nitric oxide synthase; Mitogen activated protein kinase; Nuclear factor B

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; CYTOKINE; ECKLONIA CAVA EXTRACT; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PLANT EXTRACT; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BROWN ALGA; CELL VIABILITY; CONCENTRATION RESPONSE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DNA BINDING; ECKLONIA CAVA; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; KOREA; MICROGLIA; MOUSE; NEUROPROTECTION; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEAWEED; WESTERN BLOTTING;

ALGAE, BROWN; ANIMALS; CELL LINE; CELL SURVIVAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES;

ECKLONIA CAVA; MURINAE; PHAEOPHYCEAE;

EID: 58149518005     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2008.11.041     Document Type: Article

References (50)

1. Ahn G., Hwang I., Park E., Kim J., Jeon Y.J., Lee J., Park J.W., and Jee Y. Immunomodulatory effects of an enzymatic extract from Ecklonia cava on murine splenocytes. Mar. Biotechnol. (NY) 10 (2008) 278-289
2. Ahn M.J., Yoon K.D., Min S.Y., Lee J.S., Kim J.H., Kim T.G., Kim S.H., Kim N.G., Huh H., and Kim J. Inhibition of HIV-1 reverse transcriptase and protease and protease by phlorotannins from the brown algae Ecklonia cava. Biol. Pharm. Bull. 27 (2004) 544-547
3. Arvin B., Neville L.F., Barone F.C., and Feuerstein G.Z. Brain injury and inflammation. A putative role for TNF alpha. Ann. NY Acad. Sci. 765 (1995) 62-71
4. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12 (1994) 141-179
5. Baldwin Jr. A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14 (1996) 649-683
6. Bocchini V., Mazzolla R., Barluzzi R., Blasi E., Sick P., and Kettenmann H. An immortalized cell line expresses properties of activated microglial cells. J. Neurosci. Res. 31 (1992) 616-621
7. Brown G.C., and Bal-Price A. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol. Neurobiol. 27 (2003) 325-355
8. Brown G.C. Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem. Soc. Trans. 35 (2007) 1119-1121
9. Cho K.J., Yun C.H., Yoon D.Y., Cho Y.S., Rimbach G., Packer L., and Chung A.S. Effect of bioflavonoids extracted from the bark of Pinus maritima on proinflammatory cytokine interleukin-1 production in lipopolysaccharide-stimulated RAW 264.7. Toxicol. Appl. Pharmacol. 68 (2000) 64-71
10. Coker R.K., and Laurent G.J. Pulmonary fibrosis. Cytokines in the balance. Eur. Respir. J. 11 (1998) 1218-1221
11. Coleman R.A., and Smith W.L. Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46 (1994) 205-229
12. De Nardin E. The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease. Ann. Periodontol. 6 (2001) 30-40
13. Dobrenis K. Microglia in cell culture and in transplantation therapy for central nervous system disease. Methods 16 (1998) 320-344
14. Floyd R.A. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 222 (1999) 236-245
15. Gloire G., Legrand-Poels S., and Piette J. NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 72 (2006) 1493-1505
16. Griffin W.S., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L., and Arazo C. Brain interleukin 1 and S-100 immunoreactivity are elevated in down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86 (1989) 7611-7615
17. Hawkey C.J. Cox-2 inhibitors. Lancet 353 (1999) 307-314
18. Heneka M.T., and Feinstein D.L. Expression and function of inducible nitric oxide synthase in neurons. J. Neuroimmunol. 114 (2001) 8-18
19. Heo S.J., Park E.J., Lee K.W., and Jeon Y.J. Antioxidant activities of enzymatic extracts from brown seaweeds. Bioresour. Technol. 96 (2005) 1613-1623
20. Hirota K., Murata M., Sachi Y., Nakamura H., and Takeuchi J. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-κB. J. Biol. Chem. 274 (1999) 27891-27897
21. Hou R.C., Chen Y.S., Chen C.H., Chen Y.H., and Jeng K.C. Protective effect of 1,2,4-benzenetriol on LPS-induced NO production by BV2 microglial cells. J. Biomed. Sci. 13 (2006) 89-99
22. Kang H.S., Chung H.Y., Kim J.Y., Son B.W., Jung H.A., and Choi J.S. Inhibitory phlorotannins from the edible brown alga Ecklonia stolonifera on total reactive oxygen species (ROS) generation. Arch. Pharm. Res. 27 (2004) 194-198
23. Kim M.M., Ta Q.V., Mendis E., Rajapakse N., Jung W.K., Byun H.G., Jeon Y.J., and Kim S.K. Phlorotannins in Ecklonia cava extract inhibits matrix metalloproteinase activity. Life Sci. 79 (2006) 1436-1443
24. Kim S.K., Lee D.Y., Jung W.K., Kim J.H., Choi I., Park S.G., Seo S.K., Lee S.W., Lee C.M., Yea S.S., Choi Y.H., and Choi I.W. Effects of Ecklonia cava ethanolic extracts on airway hyperresponsiveness and inflammation in a murine asthma model: Role of suppressor of cytokine signaling. Biomed. Pharmacother. 62 (2008) 289-296
25. Kim Y.J., Hwang S.Y., Oh E.S., Oh S., and Han I.O. IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways. J. Neurosci. Res. 84 (2006) 1037-1046
26. Lawson L.J., Perry V.H., Dri P., and Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39 (1990) 151-170
27. Lee A.K., Sung S.H., Kim Y.C., and Kim S.G. Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on I-κBα phosphorylation, C/EBP and AP-1 activation. Br. J. Pharmacol. 139 (2003) 11-20
28. Lehnardt S., Massillon L., Follett P., Jensen F.E., Ratan R., Rosenberg P.A., Volpe J.J., and Vartanian T. Activation of innate immunity in the CNS triggers neurodegeneration through a toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. USA 100 (2003) 8514-8519
29. Licastro F., Pedrini S., Casadei V., Govoni M., Pession A., Sciacca F.L., Veglia F., Annoni G., Bonafè M., Olivieri F., Franceschi C., and Grimaldi L.M. Gene polymorphism affecting α-1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann. Neurol. 48 (2000) 388-391
30. MacMicking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage function. Ann. Rev. Immunol. 15 (1997) 323-330
31. Ma Q., Kinneer K., Ye J., and Chen B.J. Inhibition of nuclear factor κB by phenolic antioxidants: interplay between antioxidant signaling and inflammatory cytokine expression. Mol. Pharmacol. 64 (2003) 211-219
32. Meda L., Cassatella M.A., Szendrei G.I., Otvos L., Baron P., Villalba M., Ferrari D., and Rossi F. Activation of microglial cells by -amyloid protein and interferon-γ. Nature 374 (1995) 647-650
33. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J. Neuropathol. Exp. Neurol. 63 (2004) 901-910
34. Mitchell J.A., Larkin S., and Williams T.J. Cyclooxygenase-2: regulation and relevance in inflammation. Biochem. Pharmacol. 50 (1995) 1535-1542
35. Moon D.O., Choi Y.H., Kim N.D., Park Y.M., and Kim G.Y. Anti-inflammatory effects of beta-lapachone in lipopolysaccharide-stimulated BV2 microglia. Int. Immunopharmacol. 7 (2007) 506-514
36. Mosley R.L., Benner E.J., Kadiu I., Thomas M., Boska M.D., Hasan K., Laurie C., and Gendelman H.E. Neuroinflammation, oxidative stress and the pathogenesis of Parkinson's disease. Clin. Neurosci. Res. 6 (2006) 261-281
37. Murphy S. Production of nitric oxide by glial cells: regulation and potential roles in the CNS. Glia 29 (2000) 1-13
38. Pasinetti G.M., and Aisen P.S. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 87 (1998) 319-324
39. Pergola C., Rossi A., Dugo P., Cuzzocrea S., and Sautebin L. Inhibition of nitric oxide biosynthesis by anthocyanin fraction of blackberry extract. Nitric Oxide 15 (2006) 30-39
40. Picot D., Loll P.J., and Garavito R.M. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature 367 (1994) 243-249
41. Selmaj W.K., and Raine C.S. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23 (1988) 339-346
42. Shin H.C., Hwang H.J., Kang K.J., and Lee B.H. An antioxidative and antiinflammatory agent for potential treatment of osteoarthritis from Ecklonia cava. Arch. Pharm. Res. 29 (2006) 165-171
43. Shohami E., Bass A., Wallach D., Yamin A., and Gallily R. Inhibition of TNF alpha activity in rat brain is associated with cerebroprotection after closed head injury. J. Cereb. Blood Flow Metab. 16 (1993) 378-384
44. Smith W.L., Garavito R.M., and Dewitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenase)-1 and -2. J. Biol. Chem. 271 (1996) 33157-33160
45. Suh S.J., Chung T.W., Son M.J., Kim S.H., Moon T.C., Son K.H., Kim H.P., Chang H.W., and Kim C.H. The naturally occurring biflavonoid, ochnaflavone, inhibits LPS-induced iNOS expression, which is mediated by ERK1/2 via NF-kappaB regulation, in RAW264.7 cells. Arch. Biochem. Biophys. 447 (2006) 136-146
46. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., and Lee S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat. Res. (2001) 243-268
47. Vane J.R., Mitchell J.A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., and Willoughby D.A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA 91 (1994) 2046-2050
48. Vegeto E., Bonincontro C., Pollio G., Sala A., Viappiani S., Nardi F., Brusadelli A., Viviani B., Ciana P., and Maggi A. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J. Neurosci. 21 (2001) 1809-1818
49. Woo M.S., Jung S.H., Hyun J.W., and Kim H.S. Differential regulation of inducible nitric oxide synthase and cytokine gene expression by forskolin and dibutyryl-cAMP in lipopolysaccharide-stimulated murine BV2 microglial cells. Neurosci. Lett. 356 (2004) 187-190
50. Zielasek J., and Hartung H.P. Molecular mechanisms of microglial activation. Adv. Neuroimmunol. 6 (1996) 191-222